Compositions and methods of use for tyrosine kinase inhibitors to treat pathogenic infection
US8765777B2 · kind B2 · utility
2Cited by
4References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 16, 2010 |
| Grant date | Jul 1, 2014 |
| Priority date | — |
| Expiry date | Dec 16, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods are provided for using tyrosine kinase inhibitors to treat pathogenic infection. In particular, methods for using Abl-family tyrosine kinase inhibitors to treat pathogenic infection are provided. Infections to be treated according to the present invention include, particularly, those caused by microbial pathogens such as bacteria and viruses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.